Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Kehl

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Bone Reports|April 29, 2024
A novel entity of massive multifocal osteolyses in the elderlyPatrick Orth, Phillip Rolf Stahl, Wolfgang Tränkenschuh, et al.
Nucleic Acids Research|May 5, 2017
RegulatorTrail: a web service for the identification of key transcriptional regulatorsTim Kehl, Lara Schneider, Florian Schmidt, et al.
Nucleic Acids Research|May 19, 2021
miRTargetLink 2.0-interactive miRNA target gene and target pathway networksFabian Kern, Ernesto Aparicio-Puerta, Yongping Li, et al.
Journal for Immunotherapy of Cancer|July 18, 2019
miR-34a as hub of T cell regulation networksMartin Hart, Barbara Walch-Rückheim, Lena Krammes, et al.
Journal for Immunotherapy of Cancer|November 24, 2020
Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4<sup>+</sup>, CD8<sup>+</sup> T cells, and M1 macrophagesMartin Hart, Laura Nickl, Barbara Walch-Rueckheim, et al.
Bioinformatics (Oxford, England)|January 21, 2016
Multi-omics enrichment analysis using the GeneTrail2 web serviceDaniel Stöckel, Tim Kehl, Patrick Trampert, et al.
Cell Death Discovery|January 21, 2023
Time-resolved RNA signatures of CD4+ T cells in Parkinson's diseaseCaroline Diener, Martin Hart, Tim Kehl, et al.
International Journal of Cancer|August 30, 2018
The role of TCF3 as potential master regulator in blastemal Wilms tumorsTim Kehl, Lara Schneider, Kathrin Kattler, et al.
Nucleic Acids Research|September 29, 2020
Quantitative and time-resolved miRNA pattern of early human T cell activationCaroline Diener, Martin Hart, Tim Kehl, et al.
International Journal of Cancer|October 27, 2015
DrugTargetInspector: An assistance tool for patient treatment stratificationLara Schneider, Daniel Stöckel, Tim Kehl, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Bone Reports|April 29, 2024
A novel entity of massive multifocal osteolyses in the elderlyPatrick Orth, Phillip Rolf Stahl, Wolfgang Tränkenschuh, et al.
Nucleic Acids Research|May 5, 2017
RegulatorTrail: a web service for the identification of key transcriptional regulatorsTim Kehl, Lara Schneider, Florian Schmidt, et al.
Nucleic Acids Research|May 19, 2021
miRTargetLink 2.0-interactive miRNA target gene and target pathway networksFabian Kern, Ernesto Aparicio-Puerta, Yongping Li, et al.
Journal for Immunotherapy of Cancer|July 18, 2019
miR-34a as hub of T cell regulation networksMartin Hart, Barbara Walch-Rückheim, Lena Krammes, et al.
Journal for Immunotherapy of Cancer|November 24, 2020
Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4<sup>+</sup>, CD8<sup>+</sup> T cells, and M1 macrophagesMartin Hart, Laura Nickl, Barbara Walch-Rueckheim, et al.
Bioinformatics (Oxford, England)|January 21, 2016
Multi-omics enrichment analysis using the GeneTrail2 web serviceDaniel Stöckel, Tim Kehl, Patrick Trampert, et al.
Cell Death Discovery|January 21, 2023
Time-resolved RNA signatures of CD4+ T cells in Parkinson's diseaseCaroline Diener, Martin Hart, Tim Kehl, et al.
International Journal of Cancer|August 30, 2018
The role of TCF3 as potential master regulator in blastemal Wilms tumorsTim Kehl, Lara Schneider, Kathrin Kattler, et al.
Nucleic Acids Research|September 29, 2020
Quantitative and time-resolved miRNA pattern of early human T cell activationCaroline Diener, Martin Hart, Tim Kehl, et al.
International Journal of Cancer|October 27, 2015
DrugTargetInspector: An assistance tool for patient treatment stratificationLara Schneider, Daniel Stöckel, Tim Kehl, et al.
Pageof 3